Stocks in the Vines Investor Access Day Highlights
Stocks in the Vines Investor Access Day, held at Marnong Estate, Victoria, where standout presentations included:
BlinkLab Limited (ASX:BB1) – demonstrating how its app is revolutionising medtech through early autism diagnosis in children.
Decidr AI Industries Ltd (ASX:DAI) – outlining how Decidr and AWS are powering the next wave of AI-driven business solutions.
Zelira Therapeutics (ASX:ZLD) – showcasing advancements in medicinal cannabis treatments for Phelan-McDermid Syndrome and autism spectrum disorders.
Political Debate Panel
Panelists Kos Samaras Tony Barry Danni Hunter Anthony Koutoufides debated to how the 2025 election could shape market trends and investor confidence? In this debate, experts share diverse perspectives on the potential impacts, exploring opportunities, risks, and the broader economic outlook.
Hear insightful arguments and contrasting views on what the election could mean for the future of the stock market:
Decidr AI (ASX:DAI) - Transforming Business with Innovation
Presentation - David Brudenell
David Brudenell, Executive Chairman at Decidr AI (ASX:DAI) presentation update. David shares how the company is revolutionizing businesses worldwide through its unique technology. Discover the vision, the impact, and the opportunities Decidr AI is creating in the global market.
2025 Stocks in the Vines Investor Access Day Company Presentation:
Tim Slate, Non-Executive Director of Zelira Therapeutics (ASX:ZLD) on how they are driving innovation and change in medicinal cannabis for Phelan McDermind Syndrome and Autism:
Company testimonial:
“We appreciated getting to present to high quality investors from Melbourne-based funds and stockbrokers to high-net-worth individuals. The combination of fine wine, a beautiful setting, and interesting people made it feel more like a social function than a traditional capital-raising event. If you're a company looking to engage with serious investors in a meaningful way, this is the event to attend.”
Tim Slate, Non-Executive Director
Zelira Therapeutics (ASX:ZLD)
Stocks in the Vines Investor Access Day Highlights
Stocks in the Vines Investor Access Day, held at Marnong Estate, Victoria, where standout presentations included:
BlinkLab Limited (ASX:BB1) – demonstrating how its app is revolutionising medtech through early autism diagnosis in children.
Decidr AI Industries Ltd (ASX:DAI) – outlining how Decidr and AWS are powering the next wave of AI-driven business solutions.
Zelira Therapeutics (ASX:ZLD) – showcasing advancements in medicinal cannabis treatments for Phelan-McDermid Syndrome and autism spectrum disorders.
Political Debate Panel
Panelists Kos Samaras Tony Barry Danni Hunter Anthony Koutoufides debated to how the 2025 election could shape market trends and investor confidence? In this debate, experts share diverse perspectives on the potential impacts, exploring opportunities, risks, and the broader economic outlook.
Hear insightful arguments and contrasting views on what the election could mean for the future of the stock market:
Decidr AI (ASX:DAI) - Transforming Business with Innovation
Presentation - David Brudenell
David Brudenell, Executive Chairman at Decidr AI (ASX:DAI) presentation update. David shares how the company is revolutionizing businesses worldwide through its unique technology. Discover the vision, the impact, and the opportunities Decidr AI is creating in the global market.
2025 Stocks in the Vines Investor Access Day Company Presentation:
Tim Slate, Non-Executive Director of Zelira Therapeutics (ASX:ZLD) on how they are driving innovation and change in medicinal cannabis for Phelan McDermind Syndrome and Autism:
Company testimonial:
